Über uns

Sysmex Inostics, a subsidiary of Sysmex Corporation is a molecular diagnostics company that is a pioneer in blood-based cell-free tumor DNA testing in oncology. We are a trusted partner to leading pharmaceutical companies, advancing their efforts to bring the most effective personalized cancer therapies and solutions to global markets. We offer blood and tissue testing services in our laboratories in Hamburg Germany and Baltimore Maryland USA (in addition to facilities in Japan and China).

Our highly sensitive OncoBEAM™ (BEAMing) digital PCR and SafeSEQ (Next Generation Sequencing) technologies can detect minute amounts of mutant DNA circulating in the bloodstream to identify gene mutations and improve the characterization of tumors, enabling personalized medicine to tailor treatment to the individual cancer patient. With these technologies we support clinical researchers and oncologists with therapy selection and monitoring of response, recurrence as well as resistance.